Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Phase 2: To compare overall survival (OS) in patients with Stage II-IV unresectable pancreatic cancer when treated with the combination of LY2157299 monohydrate and gemcitabine with that of gemcitabine plus placebo.
Critère d'inclusion
- Phase 2: Advanced or Metastatic Unresectable Pancreatic Cancer